Diagnostic imaging agents with MMP inhibitory activity

Details for Australian Patent Application No. 2004210208 (hide)

Owner GE Healthcare Limited

Inventors Davis, Julie; Wynn, Duncan; Cuthbertson, Alan; Storey, Anthony; Schafers, Michael; Arukwe, Joseph; Kopka, Klaus; Mendizabal, Marivi; Heywood, Kirsty; Levkau, Bodu; Ricketts, Sally-Ann; Breyholz, Hans-Jorg; Wilson, Ian; Wagner, Stefan

Agent Davies Collison Cave

Pub. Number AU-B-2004210208

PCT Pub. Number WO2004/069365

Priority 0307524.9 01.04.03 GB; 0302891.7 10.02.03 GB

Filing date 10 February 2004

Wipo publication date 19 August 2004

Acceptance publication date 7 June 2007

International Classifications

A61K 51/04 (2006.01) Preparations containing radioactive substances for use in therapy or testing

Event Publications

18 August 2005 PCT application entered the National Phase

  PCT publication WO2004/069365 Priority application(s): WO2004/069365

7 June 2007 Application Accepted

  Published as AU-B-2004210208

4 October 2007 Standard Patent Sealed

3 September 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004210210-A support element for an integrated module for blood treatment

2004210207-Treatment of inflammatory bowel disease